Suppr超能文献

新型冠状病毒肺炎的变化特征:意大利南部感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔(B.1.617.2)和阿尔法(B.1.1.7)变体的特点

Changing Features of COVID-19: Characteristics of Infections with the SARS-CoV-2 Delta (B.1.617.2) and Alpha (B.1.1.7) Variants in Southern Italy.

作者信息

Loconsole Daniela, Centrone Francesca, Morcavallo Caterina, Campanella Silvia, Accogli Marisa, Sallustio Anna, Peccarisi Davide, Stufano Angela, Lovreglio Piero, Chironna Maria

机构信息

Department of Biomedical Sciences and Human Oncology-Hygiene Section, School of Medicine, University of Bari, 70124 Bari, Italy.

Hygiene Unit, Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, 70124 Bari, Italy.

出版信息

Vaccines (Basel). 2021 Nov 18;9(11):1354. doi: 10.3390/vaccines9111354.

Abstract

Differences in the demographic and clinical characteristics of patients infected with the Alpha and Delta SARS-CoV-2 variants of concern in a large region of Southern Italy were assessed. Two cohorts of positive patients were compared. The Alpha group consisted of 11,135 subjects diagnosed between 21 March and 21 April 2021, and the Delta group consisted of 499 positive subjects diagnosed between 21 July and 21 August 2021. A descriptive and statistical analysis of the demographic and clinical characteristics of the two groups was performed. The proportion of patients with mild and moderate infections was significantly higher in the Delta than in the Alpha group ( < 0.001). In fully vaccinated patients, the proportion of symptomatic individuals was significantly higher in the Delta than in the Alpha group. The Delta group showed odds ratios of 3.08 (95% CI, 2.55-3.72) for symptomatic infection and 2.66 (95% CI, 1.76-3.94) for hospitalization. Improving COVID-19 vaccination rates is a priority, since infection with the SARS-CoV-2 Delta variant has a significant impact on patient outcomes. Additional targeted prevention strategies such as social distancing, the use of masks in indoor settings irrespective of vaccination status, and the use of a sanitary passport could be crucial to contain further spread of SARS-CoV-2 infection.

摘要

对意大利南部一个大区域内感染新冠病毒变异株阿尔法和德尔塔的患者的人口统计学和临床特征差异进行了评估。比较了两组阳性患者。阿尔法组由2021年3月21日至4月21日期间确诊的11135名受试者组成,德尔塔组由2021年7月21日至8月21日期间确诊的499名阳性受试者组成。对两组的人口统计学和临床特征进行了描述性和统计分析。德尔塔组轻度和中度感染患者的比例显著高于阿尔法组(<0.001)。在完全接种疫苗的患者中,德尔塔组有症状个体的比例显著高于阿尔法组。德尔塔组有症状感染的优势比为3.08(95%CI,2.55 - 3.72),住院的优势比为2.66(95%CI,1.76 - 3.94)。提高新冠疫苗接种率是当务之急,因为感染新冠病毒德尔塔变异株对患者预后有重大影响。额外的针对性预防策略,如保持社交距离、无论疫苗接种状况如何在室内环境中佩戴口罩以及使用健康通行证,对于遏制新冠病毒感染的进一步传播可能至关重要。

相似文献

2
Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021.
MMWR Morb Mortal Wkly Rep. 2021 Oct 8;70(40):1415-1419. doi: 10.15585/mmwr.mm7040a4.
7
No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway.
Int J Infect Dis. 2022 Feb;115:178-184. doi: 10.1016/j.ijid.2021.12.321. Epub 2021 Dec 11.
8
Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020-March 2021).
Int J Environ Res Public Health. 2021 Apr 29;18(9):4766. doi: 10.3390/ijerph18094766.

引用本文的文献

2
From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World.
Biology (Basel). 2023 Sep 21;12(9):1267. doi: 10.3390/biology12091267.
6
The impact of COVID-19 vaccination programme in the Republic of San Marino: Focus on effectiveness of Gam-Covid-Vac.
Clin Microbiol Infect. 2022 Dec;28(12):1636-1643. doi: 10.1016/j.cmi.2022.06.026. Epub 2022 Jul 4.
8
Clinical challenges of SARS-CoV-2 variants (Review).
Exp Ther Med. 2022 Jun;23(6):416. doi: 10.3892/etm.2022.11343. Epub 2022 Apr 28.
9
Efficient Framework for Detection of COVID-19 Omicron and Delta Variants Based on Two Intelligent Phases of CNN Models.
Comput Math Methods Med. 2022 Apr 21;2022:4838009. doi: 10.1155/2022/4838009. eCollection 2022.
10
Qingjin Yiqi granules for post-COVID-19 condition: A randomized clinical trial.
J Evid Based Med. 2022 Mar;15(1):30-38. doi: 10.1111/jebm.12465.

本文引用的文献

1
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
Lancet. 2021 Nov 13;398(10313):1825-1835. doi: 10.1016/S0140-6736(21)02276-5. Epub 2021 Oct 28.
2
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
Lancet. 2021 Oct 16;398(10309):1407-1416. doi: 10.1016/S0140-6736(21)02183-8. Epub 2021 Oct 4.
3
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel.
N Engl J Med. 2021 Oct 7;385(15):1393-1400. doi: 10.1056/NEJMoa2114255. Epub 2021 Sep 15.
5
Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021.
Euro Surveill. 2021 Sep;26(35). doi: 10.2807/1560-7917.ES.2021.26.35.2100793.
8
Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
JAMA. 2021 Sep 21;326(11):1001-1002. doi: 10.1001/jama.2021.14811.
9
10
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验